Gout is the most common inflammatory arthritis affecting 1-2% of the population. It is a very common problem presenting to ...

A medication commonly used to treat gout could be the key to reducing a cardiovascular condition that puts one in five people aged over 75 at risk of ...

The Shenzhen, China-based biotech plans to launch a Phase I trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IN026.

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a person’s risk of other health conditions.